Data for CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
Organisation | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|
LONDON COMMISSIONING REGION | 4140 | 4485 | 92.3% | 100 |
LONDON STRATEGIC HEALTH AUTHORITY | 4146 | 4492 | 92.3% | 100 |
YORKSHIRE AND THE HUMBER … | 3582 | 3906 | 91.7% | 90 |
EAST OF ENGLAND STRATEGIC … | 3429 | 3742 | 91.6% | 80 |
MIDLANDS AND EAST OF … | 10260 | 11232 | 91.3% | 75 |
WEST MIDLANDS STRATEGIC HEALTH … | 3947 | 4321 | 91.3% | 70 |
SOUTH CENTRAL STRATEGIC HEALTH … | 2750 | 3017 | 91.1% | 60 |
NHS England | 36008 | 39518 | 91.1% | |
EAST MIDLANDS STRATEGIC HEALTH … | 2782 | 3055 | 91.1% | 50 |
UK | 43144 | 47418 | 91.0% | |
NORTH OF ENGLAND COMMISSIONING … | 12432 | 13669 | 91.0% | 50 |
NORTH EAST STRATEGIC HEALTH … | 2497 | 2750 | 90.8% | 40 |
SOUTH OF ENGLAND COMMISSIONING … | 9518 | 10495 | 90.7% | 25 |
SOUTH WEST STRATEGIC HEALTH … | 4204 | 4640 | 90.6% | 30 |
SOUTH EAST COAST STRATEGIC … | 2680 | 2964 | 90.4% | 20 |
NORTH WEST STRATEGIC HEALTH … | 5991 | 6631 | 90.3% | 10 |